Application 202230
- Type
- ANDA
- Sponsor
- MACLEODS PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 25MG | No | No |
| 002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 50MG | No | No |
| 003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | TABLET;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202230-001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | |
| A202230-002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | |
| A202230-003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A202230-001 | AB |
| A202230-002 | AB |
| A202230-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202230-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2012-05-30 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202230-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2012-05-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202230-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2012-05-30 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A202230-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A202230-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A202230-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A202230-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202230-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202230-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202230-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202230-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202230-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A202230-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202230-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202230-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202230-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202230-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202230-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202230-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202230-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202230-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202230-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202230-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202230-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202230-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202230-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202230-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202230-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202230-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202230-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202230-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202230-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202230-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A202230-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A202230-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A202230-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202230-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202230-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202230-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202230-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202230-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202230-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202230-001 | AB | 1 | 1e350fbaab3a… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan potassium | LOSARTAN POTASSIUM | Preferred Pharmaceuticals Inc. | 628d0317-b844-42a0-9c27-48e1e23a38f5 | 2026-06-09 | Boxed warning, Warnings, Adverse reactions | 202230 ANDA202230 |
| Losartan potassium | LOSARTAN POTASSIUM | REMEDYREPACK INC. | a397502e-abe7-49cf-97c7-d53a616947eb | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 202230 ANDA202230 |
| Losartan potassium | LOSARTAN POTASSIUM | Macleods Pharmaceuticals Limited | 85d69d02-c5ef-467e-94aa-903100218795 | 2025-07-28 | Boxed warning, Warnings, Adverse reactions | 202230 ANDA202230 33342-044 33342-045 33342-046 |
| Losartan potassium | LOSARTAN POTASSIUM | Coupler LLC | 2d1b1648-8b24-cf4f-e063-6294a90afdd8 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | 202230 ANDA202230 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 33342-044 | Losartan potassium | Losartan potassium | Macleods Pharmaceuticals Limited | ANDA | Current |
| 33342-044 | Losartan potassium | Losartan potassium | Macleods Pharmaceuticals Limited | ANDA | Current |
| 33342-045 | Losartan potassium | Losartan potassium | Macleods Pharmaceuticals Limited | ANDA | Current |
| 33342-045 | Losartan potassium | Losartan potassium | Macleods Pharmaceuticals Limited | ANDA | Current |
| 33342-046 | Losartan potassium | Losartan potassium | Macleods Pharmaceuticals Limited | ANDA | Current |
| 33342-046 | Losartan potassium | Losartan potassium | Macleods Pharmaceuticals Limited | ANDA | Current |
| 68071-4036 | Losartan potassium | Losartan potassium | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4062 | Losartan potassium | Losartan potassium | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4244 | Losartan potassium | Losartan potassium | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4248 | Losartan potassium | Losartan potassium | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 70934-932 | Losartan potassium | Losartan potassium | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | ANDA | Current |